» Articles » PMID: 32757051

Risk Stratification of Thymic Epithelial Tumors by Using a Nomogram Combined with Radiomic Features and TNM Staging

Overview
Journal Eur Radiol
Specialty Radiology
Date 2020 Aug 7
PMID 32757051
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To construct and validate a nomogram model that integrated the CT radiomic features and the TNM staging for risk stratification of thymic epithelial tumors (TETs).

Methods: A total of 136 patients with pathology-confirmed TETs who underwent CT examination were collected from two institutions. According to the WHO pathological classification criteria, patients were classified into low-risk and high-risk groups. The TNM staging was determined in terms of the 8th edition AJCC/UICC staging criteria. LASSO regression was performed to extract the optimal features correlated to risk stratification among the 704 radiomic features calculated. A nomogram model was constructed by combining the Radscore and the TNM staging. The clinical performance was evaluated by ROC analysis, calibration curve, and decision curve analysis (DCA). The Kaplan-Meier (KM) analysis was employed for survival analysis.

Results: Five optimal features identified by LASSO regression were employed to calculate the Radscore correlated to risk stratification. The nomogram model showed a better performance in both training cohort (AUC = 0.84, 95%CI 0.75-0.91) and external validation cohort (AUC = 0.79, 95%CI 0.69-0.88). The calibration curve and DCA analysis indicated a better accuracy of the nomogram model for risk stratification than either Radscore or the TNM staging alone. The KM analysis showed a significant difference between the two groups stratified by the nomogram model (p = 0.02).

Conclusions: A nomogram model that integrated the radiomic signatures and the TNM staging could serve as a reliable model of risk stratification in predicting the prognosis of patients with TETs.

Key Points: • The radiomic features could be associated with the TET pathophysiology. • TNM staging and Radscore could independently stratify the risk of TETs. • The nomogram model is more objective and more comprehensive than previous methods.

Citing Articles

Application of machine learning for the differentiation of thymomas and thymic cysts using deep transfer learning: A multi-center comparison of diagnostic performance based on different dimensional models.

Yang Y, Cheng J, Chen L, Cui C, Liu S, Zuo M Thorac Cancer. 2024; 15(31):2235-2247.

PMID: 39305057 PMC: 11543273. DOI: 10.1111/1759-7714.15454.


Multimodal modeling with low-dose CT and clinical information for diagnostic artificial intelligence on mediastinal tumors: a preliminary study.

Yamada D, Kojima F, Otsuka Y, Kawakami K, Koishi N, Oba K BMJ Open Respir Res. 2024; 11(1).

PMID: 38589197 PMC: 11015206. DOI: 10.1136/bmjresp-2023-002249.


Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures.

Zhang X, Zhang P, Cong A, Feng Y, Chi H, Xia Z Front Immunol. 2023; 14:1264325.

PMID: 37849766 PMC: 10577431. DOI: 10.3389/fimmu.2023.1264325.


Diagnostic performance of radiomics model for preoperative risk categorization in thymic epithelial tumors: a systematic review and meta-analysis.

Lu X, Zhu T BMC Med Imaging. 2023; 23(1):115.

PMID: 37644397 PMC: 10466844. DOI: 10.1186/s12880-023-01083-6.


A novel risk classifier for predicting the overall survival of patients with thymic epithelial tumors based on the eighth edition of the TNM staging system: A population-based study.

Li Y, Jiang A, Zhao Y, Shi C, Ma Y, Fu X Front Endocrinol (Lausanne). 2022; 13:1050364.

PMID: 36561557 PMC: 9763871. DOI: 10.3389/fendo.2022.1050364.


References
1.
Engels E . Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010; 5(10 Suppl 4):S260-5. PMC: 2951303. DOI: 10.1097/JTO.0b013e3181f1f62d. View

2.
Travis W, Brambilla E, Nicholson A, Yatabe Y, Austin J, Beasley M . The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015; 10(9):1243-1260. DOI: 10.1097/JTO.0000000000000630. View

3.
Detterbeck F, Moran C, Huang J, Suster S, Walsh G, Kaiser L . [Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy]. Zhongguo Fei Ai Za Zhi. 2014; 17(2):95-103. PMC: 6131236. DOI: 10.3779/j.issn.1009-3419.2014.02.06. View

4.
Filosso P, Ruffini E, Lausi P, Lucchi M, Oliaro A, Detterbeck F . Historical perspectives: The evolution of the thymic epithelial tumors staging system. Lung Cancer. 2014; 83(2):126-32. DOI: 10.1016/j.lungcan.2013.09.013. View

5.
Kondo K, Van Schil P, Detterbeck F, Okumura M, Stratton K, Giroux D . The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014; 9(9 Suppl 2):S81-7. DOI: 10.1097/JTO.0000000000000291. View